Gertraud Orend Selected Research

Gertraud Orend Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 06/2003
12	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2006
8	Inflammation (Inflammations) 01/2022 - 07/2009
8	Carcinogenesis 11/2015 - 10/2004
7	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2005
4	Glioblastoma (Glioblastoma Multiforme) 12/2016 - 10/2004
4	Glioma (Gliomas) 12/2016 - 10/2004
2	Fibrosis (Cirrhosis) 01/2022 - 01/2018
2	Infections 01/2021 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 06/2018 - 12/2012
2	Colorectal Neoplasms (Colorectal Cancer) 06/2018 - 11/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 10/2013
1	Cicatrix (Scar) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Glomerulonephritis 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Ulcerative Colitis 01/2021
1	Carcinoma (Carcinomatosis) 06/2018
1	Primitive Neuroectodermal Tumors (PNET) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Adenoma (Adenomas) 11/2015
1	Colitis 01/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2014
1	Colitis-Associated Neoplasms 01/2014
1	Wounds and Injuries (Trauma) 01/2012
1	Atherosclerotic Plaque (Atheroma) 01/2011
1	Atherosclerosis 01/2011
1	Heart Failure 12/2009
1	Joint Diseases (Joint Disease) 07/2009
1	Rheumatoid Arthritis 07/2009
1	Arthritis (Polyarthritis) 07/2009
1	Genomic Instability 05/2005
1	Astrocytoma (Pilocytic Astrocytoma) 10/2004

Drug/Important Bio-Agent (IBA)

31	TenascinIBA 01/2022 - 06/2003
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
5	Fibronectins (Fibronectin)IBA 01/2021 - 10/2004
5	Peptides (Polypeptides)IBA 10/2019 - 12/2012
3	CytokinesIBA 01/2020 - 07/2009
3	Neuropilin-1IBA 10/2019 - 01/2016
2	AntibodiesIBA 01/2022 - 01/2020
2	LipopolysaccharidesIBA 01/2022 - 01/2021
2	CarcinogensIBA 01/2021 - 01/2014
2	Monoclonal AntibodiesIBA 01/2020 - 12/2012
2	Toll-Like Receptor 4IBA 01/2020 - 07/2009
2	IntegrinsIBA 06/2018 - 01/2018
2	Laminin (Merosin)IBA 06/2018 - 01/2014
2	Glycoproteins (Glycoprotein)IBA 01/2018 - 07/2009
2	Extracellular Matrix ProteinsIBA 06/2014 - 06/2003
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Single-Domain AntibodiesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	ParaffinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Immune Sera (Antisera)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 10/2019
1	Phenobarbital (Luminal)FDA Link 10/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	PeriostinIBA 01/2018
1	Ephrin-B2 (Ephrin B2)IBA 12/2016
1	plexinIBA 01/2016
1	NeuropilinsIBA 01/2016
1	CateninsIBA 11/2015
1	AzoxymethaneIBA 11/2015
1	ErbB Receptors (EGF Receptor)IBA 09/2014
1	LigandsIBA 09/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2014
1	tenascin XIBA 01/2012
1	Biological ProductsIBA 07/2009
1	Platelet-Derived Growth FactorIBA 09/2008
1	RNA (Ribonucleic Acid)IBA 09/2008
1	lysophosphatidic acidIBA 09/2008
1	PaxillinIBA 09/2008
1	Endothelin Receptors (Endothelin Receptor)IBA 07/2007
1	Syndecan-4IBA 07/2007
1	Integrin alpha5beta1IBA 07/2007
1	Doxycycline (Periostat)FDA LinkGeneric 12/2005
1	Endothelins (Endothelin)IBA 10/2004

Therapy/Procedure

7	Therapeutics 01/2021 - 12/2006
1	Radiotherapy 01/2021
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 11/2014
1	Intra-Articular Injections 07/2009